Practical Improvements for Medical Device Evaluation.
作者信息
Kramer Daniel B, Yeh Robert W
机构信息
Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
出版信息
JAMA. 2017 Jul 25;318(4):332-334. doi: 10.1001/jama.2017.8976.
Abstract
摘要
相似文献
1
Practical Improvements for Medical Device Evaluation.医疗设备评估的实际改进措施。
JAMA. 2017 Jul 25;318(4):332-334. doi: 10.1001/jama.2017.8976.
2
Benefits of and barriers to involving users in medical device technology development and evaluation.让用户参与医疗设备技术开发和评估的益处与障碍。
Int J Technol Assess Health Care. 2007 Winter;23(1):131-7. doi: 10.1017/S0266462307051677.
3
The economic evaluation of medical devices: challenges ahead.医疗器械的经济评价：未来的挑战。
Appl Health Econ Health Policy. 2013 Feb;11(1):15-26. doi: 10.1007/s40258-012-0006-9.
4
Teaching the concept of brain death in undergraduate medical education.
J Surg Educ. 2015 May-Jun;72(3):504-8. doi: 10.1016/j.jsurg.2014.10.012. Epub 2014 Nov 20.
5
[Comments and suggestions on the medical device standardization system from the view point of medical devices test].从医疗器械检测角度对医疗器械标准化体系的评论与建议
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2013 Jun;30(3):546-51.
6
MEDICAL DEVICE PRICES IN ECONOMIC EVALUATIONS.经济评估中的医疗设备价格
Int J Technol Assess Health Care. 2015 Jan;31(1-2):86-9. doi: 10.1017/S026646231500015X. Epub 2015 May 20.
7
[Authorization procedure of clinical trials with medical devices. First practical analysis of the BfArM].[医疗器械临床试验的授权程序。联邦药品和医疗器械研究所的首次实际分析]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012 Feb;55(2):270-6. doi: 10.1007/s00103-011-1419-6.
8
9
[Practice of Medical Device Clinical Evaluation].[医疗器械临床评价实践]
Zhongguo Yi Liao Qi Xie Za Zhi. 2018 Jul 30;42(4):305-308. doi: 10.3969/j.issn.1671-7104.2018.04.022.
10
[Study on situations of review and pre-evaluation for medical device product specification in China].[中国医疗器械产品技术要求审评与预评价情况研究]
Zhongguo Yi Liao Qi Xie Za Zhi. 2013 Jul;37(4):281-4.
引用本文的文献
1
More than red tape: exploring complexity in medical device regulatory affairs.不止是繁文缛节：探索医疗器械监管事务中的复杂性
Front Med (Lausanne). 2024 Jul 31;11:1415319. doi: 10.3389/fmed.2024.1415319. eCollection 2024.
2
Development of an innovative double-chamber syringe for intravenous therapeutics and flushing: Nurses' involvement through a human-centred approach.开发一种用于静脉治疗和冲洗的创新型双腔注射器：通过以人为中心的方法让护士参与进来。
PLoS One. 2020 Jun 25;15(6):e0235087. doi: 10.1371/journal.pone.0235087. eCollection 2020.
3
Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data.利用行政索赔数据识别冠状动脉支架置入术后不良事件的归因。
J Am Heart Assoc. 2020 Feb 18;9(4):e013606. doi: 10.1161/JAHA.119.013606. Epub 2020 Feb 16.
本文引用的文献
1
Power Morcellators, Postmarketing Surveillance, and the US Food and Drug Administration.动力组织粉碎器、上市后监测与美国食品药品监督管理局
JAMA. 2017 Jul 25;318(4):325-326. doi: 10.1001/jama.2017.7704.
2
Monitoring Medical Devices: Missed Warning Signs Within Existing Data.监测医疗设备：现有数据中的警示信号遗漏
JAMA. 2017 Jul 25;318(4):327-328. doi: 10.1001/jama.2017.6584.
3
Registry-Based Prospective, Active Surveillance of Medical-Device Safety.基于注册的医疗设备安全性前瞻性主动监测
N Engl J Med. 2017 Feb 9;376(6):526-535. doi: 10.1056/NEJMoa1516333. Epub 2017 Jan 25.
4
Need for a National Evaluation System for Health Technology.对卫生技术国家评估系统的需求。
JAMA. 2016 Sep 20;316(11):1153-4. doi: 10.1001/jama.2016.8708.
5
Relationship Between Femoral Vascular Closure Devices and Short-Term Mortality From 271 845 Percutaneous Coronary Intervention Procedures Performed in the United Kingdom Between 2006 and 2011: A Propensity Score-Corrected Analysis From the British Cardiovascular Intervention Society.2006年至2011年在英国进行的271845例经皮冠状动脉介入治疗中股动脉血管闭合装置与短期死亡率的关系：来自英国心血管介入学会的倾向评分校正分析
Circ Cardiovasc Interv. 2016 Jun;9(6). doi: 10.1161/CIRCINTERVENTIONS.116.003560.
6
Effectiveness of Arterial Closure Devices for Preventing Complications With Percutaneous Coronary Intervention: An Instrumental Variable Analysis.动脉闭合装置预防经皮冠状动脉介入治疗并发症的有效性：一项工具变量分析。
Circ Cardiovasc Interv. 2016 Apr;9(4):e003464. doi: 10.1161/CIRCINTERVENTIONS.115.003464.
7
N-of-1 Policymaking--Tragedy, Trade-offs, and the Demise of Morcellation.单病例决策制定——悲剧、权衡与粉碎术的衰落
N Engl J Med. 2016 Mar 10;374(10):986-90. doi: 10.1056/NEJMms1516161.
8
Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.2010 年和 2011 年 FDA 上市前批准的高风险治疗性医疗器械全产品生命周期临床试验特点。
JAMA. 2015 Aug 11;314(6):604-12. doi: 10.1001/jama.2015.8761.
9
Assessing the safety and effectiveness of devices after US Food and Drug Administration approval: FDA-mandated postapproval studies.评估美国食品和药物管理局批准后设备的安全性和有效性：FDA 强制要求的上市后研究。
JAMA Intern Med. 2014 Nov;174(11):1773-9. doi: 10.1001/jamainternmed.2014.4194.
10
Postmarket surveillance of medical devices: a comparison of strategies in the US, EU, Japan, and China.医疗器械上市后监测：美国、欧盟、日本和中国的策略比较。
PLoS Med. 2013;10(9):e1001519. doi: 10.1371/journal.pmed.1001519. Epub 2013 Sep 24.
Zotero 插件